| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J49 | President And CEO | Buy | 53,845 | $0.79 | $42,658.77 | +0.2% | -11.8% | -14.8% | |
| Feb 19, 2025 | BSX Boston Scientific Corp | Sorenson John Bradley55 | EVP, Global Operations | Sell | 5,960 | $104.84 | $624,860.60 | -11.6% | +0.8% | -28.3% | |
| Feb 19, 2025 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 84,863 | $105.10 | $8,919,295.52 | -10.7% | +0.8% | -28.3% | |
| Feb 18, 2025 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 4,204 | $0.90 | $3,783.60 | -2.1% | +43.8% | -74.5% | |
| Feb 18, 2025 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 46,233 | $17.22 | $795,914.58 | -0.8% | +8.5% | -12.2% | |
| Feb 18, 2025 | SYK Stryker Corp | Golston Allan C. | Director | Sell | 2,458 | $383.07 | $941,586.06 | -14.2% | +2.4% | -2.1% | |
| Feb 18, 2025 | HYPR Hyperfine, Inc. | Teisseyre Thomas60 | Chief Operating Officer | Sell | 3,237 | $1.20 | $3,884.40 | -3.7% | -45.6% | -0.9% | |
| Feb 18, 2025 | BVS Bioventus Inc. | D'adamio Anthony61 | SVP &General Counsel | Sell | 4,380 | $10.19 | $44,632.20 | -3.6% | -33.3% | -18.3% | |
| Feb 18, 2025 | GEHC Ge Healthcare Technologies Inc. | Newcomb George A. | Chief Accounting Officer | Sell | 2,000 | $92.54 | $185,080.00 | -21.1% | -21.1% | -10.5% | |
| Feb 18, 2025 | BRKR Bruker Corp | Laukien Frank H65 | President &CEO | Buy | 20,000 | $50.92 | $1,018,329.76 | - | -25.5% | -21.7% | |
| Feb 18, 2025 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 8,659 | $0.90 | $7,793.10 | -3.3% | +43.8% | -74.5% | |
| Feb 18, 2025 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 11,180 | $16.86 | $188,518.22 | -0.6% | +8.5% | -12.2% | |
| Feb 18, 2025 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 9,531 | $16.86 | $160,732.37 | -0.5% | +8.5% | -12.2% | |
| Feb 18, 2025 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 1,619 | $16.77 | $27,151.60 | -9.6% | +8.5% | -12.2% | |
| Feb 18, 2025 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 24,349 | $1.88 | $45,727.42 | -11.5% | -45.5% | -12.8% | |
| Feb 18, 2025 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 100,773 | $1.88 | $189,251.69 | -6.3% | -45.5% | -12.8% | |
| Feb 18, 2025 | PACB Pacific Biosciences Of California, Inc. | Henry Christian O78 | See Remarks | Sell | 259,909 | $1.88 | $488,109.10 | -10.4% | -45.5% | -12.8% | |
| Feb 18, 2025 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 14,611 | $0.90 | $13,149.90 | -1.6% | +43.8% | -74.5% | |
| Feb 18, 2025 | BVS Bioventus Inc. | Singleton Mark Leonard46 | SVP &CFO | Sell | 6,498 | $10.19 | $66,214.62 | -5.2% | -33.3% | -18.3% | |
| Feb 18, 2025 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 6,145 | $0.90 | $5,530.50 | -3.4% | +43.8% | -74.5% | |
| Feb 18, 2025 | BVS Bioventus Inc. | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 1,537 | $10.19 | $15,662.03 | -3.0% | -33.3% | -18.3% | |
| Feb 18, 2025 | ELMD Electromed, Inc. | Skarvan Kathleen71 | Director | Sell | 76,583 | $30.48 | $2,334,281.45 | -29.6% | -25.6% | -16.0% | |
| Feb 14, 2025 | SSII Ss Innovations International, Inc. | Srivastava Sudhir | Chairman And CEO | Sell | 1,250,000 | $1.37 | $1,715,000.00 | -1.3% | - | - | |
| Feb 14, 2025 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 18,965 | $4.11 | $77,946.15 | -4.9% | -1.4% | -67.4% | |
| Feb 14, 2025 | GKOS Glaukos Corp | Navratil Tomas59 | Chief Development Officer | Sell | 3,416 | $147.14 | $502,630.24 | -4.5% | -40.2% | -28.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.